177 related articles for article (PubMed ID: 17639225)
1. Barriers to reaching the targets for tuberculosis control: multidrug-resistant tuberculosis.
Blöndal K
Bull World Health Organ; 2007 May; 85(5):387-90; discussion 391-4. PubMed ID: 17639225
[TBL] [Abstract][Full Text] [Related]
2. Critical evaluation of the Global DOTS Expansion Plan.
Enarson DA; Billo NE
Bull World Health Organ; 2007 May; 85(5):395-8; discussion 399-403. PubMed ID: 17639227
[TBL] [Abstract][Full Text] [Related]
3. Reaching the targets for tuberculosis control: the impact of HIV.
Laserson KF; Wells CD
Bull World Health Organ; 2007 May; 85(5):377-81; discussion 382-6. PubMed ID: 17639223
[TBL] [Abstract][Full Text] [Related]
4. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
van Maaren PJ
Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
[TBL] [Abstract][Full Text] [Related]
5. Did we reach the 2005 targets for tuberculosis control?
Dye C; Hosseini M; Watt C
Bull World Health Organ; 2007 May; 85(5):364-9. PubMed ID: 17639221
[TBL] [Abstract][Full Text] [Related]
6. [Tuberculosis in Asia].
Kekkaku; 2002 Oct; 77(10):693-7. PubMed ID: 12440145
[TBL] [Abstract][Full Text] [Related]
7. Multidrug-resistant tuberculosis management in resource-limited settings.
Nathanson E; Lambregts-van Weezenbeek C; Rich ML; Gupta R; Bayona J; Blöndal K; Caminero JA; Cegielski JP; Danilovits M; Espinal MA; Hollo V; Jaramillo E; Leimane V; Mitnick CD; Mukherjee JS; Nunn P; Pasechnikov A; Tupasi T; Wells C; Raviglione MC
Emerg Infect Dis; 2006 Sep; 12(9):1389-97. PubMed ID: 17073088
[TBL] [Abstract][Full Text] [Related]
8. [Multiple drug resistance: a threat for tuberculosis control].
Cardoso EM
Rev Panam Salud Publica; 2004 Jul; 16(1):68-73. PubMed ID: 15333267
[TBL] [Abstract][Full Text] [Related]
9. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.
Espinal MA; Kim SJ; Suarez PG; Kam KM; Khomenko AG; Migliori GB; Baéz J; Kochi A; Dye C; Raviglione MC
JAMA; 2000 May; 283(19):2537-45. PubMed ID: 10815117
[TBL] [Abstract][Full Text] [Related]
10. Drug-resistant tuberculosis: an insurmountable epidemic?
Chakroborty A
Inflammopharmacology; 2011 Jun; 19(3):131-7. PubMed ID: 21127999
[TBL] [Abstract][Full Text] [Related]
11. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
Pablos-Mendez A; Gowda DK; Frieden TR
Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
[TBL] [Abstract][Full Text] [Related]
12. Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs.
Zumla A; Abubakar I; Raviglione M; Hoelscher M; Ditiu L; McHugh TD; Squire SB; Cox H; Ford N; McNerney R; Marais B; Grobusch M; Lawn SD; Migliori GB; Mwaba P; O'Grady J; Pletschette M; Ramsay A; Chakaya J; Schito M; Swaminathan S; Memish Z; Maeurer M; Atun R
J Infect Dis; 2012 May; 205 Suppl 2():S228-40. PubMed ID: 22476720
[TBL] [Abstract][Full Text] [Related]
13. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
[TBL] [Abstract][Full Text] [Related]
14. Multidrug-resistant tuberculosis around the world: what progress has been made?
Falzon D; Mirzayev F; Wares F; Baena IG; Zignol M; Linh N; Weyer K; Jaramillo E; Floyd K; Raviglione M
Eur Respir J; 2015 Jan; 45(1):150-60. PubMed ID: 25261327
[TBL] [Abstract][Full Text] [Related]
15. [Fight against tuberculosis in the world].
El Kamel A; Joobeur S; Skhiri N; Cheikh Mhamed S; Mribah H; Rouatbi N
Rev Pneumol Clin; 2015; 71(2-3):181-7. PubMed ID: 24878188
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance.
Wright A; Zignol M; Van Deun A; Falzon D; Gerdes SR; Feldman K; Hoffner S; Drobniewski F; Barrera L; van Soolingen D; Boulabhal F; Paramasivan CN; Kam KM; Mitarai S; Nunn P; Raviglione M;
Lancet; 2009 May; 373(9678):1861-73. PubMed ID: 19375159
[TBL] [Abstract][Full Text] [Related]
17. Fast action urged to halt deadly TB.
Wise J
Bull World Health Organ; 2007 May; 85(5):328-9. PubMed ID: 17639211
[No Abstract] [Full Text] [Related]
18. DOTS-Plus for multidrug-resistant tuberculosis in the Philippines: global assistance urgently needed.
Tupasi TE; Quelapio MI; Orillaza RB; Alcantara C; Mira NR; Abeleda MR; Belen VT; Arnisto NM; Rivera AB; Grimaldo ER; Derilo JO; Dimarucut W; Arabit M; Urboda D
Tuberculosis (Edinb); 2003; 83(1-3):52-8. PubMed ID: 12758189
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis control in Latvia: integrated DOTS and DOTS-plus programmes.
Leimane V; Leimans J
Euro Surveill; 2006; 11(3):29-33. PubMed ID: 16567876
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
